Holen Sie sich die Stockscreener-App
0.1841
1.76%
0.0021
Schlusskurs vom Vortag:
$0.182
Offen:
$0.182
24-Stunden-Volumen:
240.39K
Relative Volume:
0.05
Marktkapitalisierung:
$2.70M
Einnahmen:
$1.10M
Nettoeinkommen (Verlust:
$-11.23M
KGV:
-0.0909
EPS:
-2.025
Netto-Cashflow:
$-6.61M
1W Leistung:
-0.43%
1M Leistung:
-34.56%
6M Leistung:
-69.32%
1J Leistung:
-88.71%
1-Tages-Spanne:
$0.182
$0.1873
1-Wochen-Bereich:
$0.173
$0.1929
52-Wochen-Spanne:
$0.173
$2.14
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.184 | 2.67M | 1.10M | -11.23M | -6.61M | -2.025 |
VRTX
Vertex Pharmaceuticals Inc
|
520.57 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
806.10 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,006.31 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.51 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.55 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Matinas BioPharma Faces NYSE American Compliance Challenges - TipRanks
Matinas BioPharma Receives New NYSE American Delisting Risk on Equity Shortfall - Minichart
Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - quiverquant.com
Matinas BioPharma Received Notice of Noncompliance - tradingview.com
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Matinas (MTNB) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 1.16% Down at the ClosePerformance Review - vinanet.vn
Hydrogen startup GH Power lines up deal with Matinas BioPharma (NYSE: MTNB) - Stock Titan
Matinas (MTNB) Session: Finishes 1.16% Down at $0.20 on the Day; Levels: the Near-Term Reference Band Stretches From $0.19 to $0.21 in the Current UpdateWave Equality - vinanet.vn
Matinas (MTNB) Q4 2024 Earnings: EPS Beats Its Estimate at the Close; Market Response: Shares Move 8.93% Higher in the Latest ReadingWeak Earnings Momentum - vinanet.vn
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Top Premarket Decliners - marketscreener.com
Matinas (MTNB) Results Review: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Market Response: The Stock Loses 8.33%Earnings Trend Analysis - vinanet.vn
Matinas Biopharma Holdings Inc. (MTNB) Q4 2024 Earnings: Narrower Loss of -$0.82 Beats Estimates as Clinical Pipeline AdvancesRevenue Warning Signal - vinanet.vn
Matinas BioPharma (MTNB) holder Adam Stern details 9.99% stake and new warrants - Stock Titan
Matinas Biopharma (MTNB) Slips 2.6% to $0.26 as Micro-Cap Biotech Tests SupportZero Gamma Level - vinanet.vn
US Micro Cap StocksInvest from India - INDmoney
Matinas BioPharma Holdings Inc (MTNB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to revenue forward of Matinas BioPharma Holdings, Inc. – FWB:6LJ0 - TradingView
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Matinas BioPharma (MTNB) to merge into new GH Power International parent - stocktitan.net
MTNB Q4 2024 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineDividend Increase Stocks - Vinanet
Matinas BioPharma (NYSE: MTNB) outlines GH Power deal and 91% post-merger stake - Stock Titan
Matinas BioPharma (MTNB) and GH Power set 91/9 split in NYSE American deal - Stock Titan
MTNB|Matinas BioPharma Holdings Inc|Price:0.335|Chg%:+0.093 - TradingKey
Matinas BioPharma Holdings Inc - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
12 Health Care Stocks Moving In Monday's Intraday SessionEntera Bio (NASDAQ:ENTX), Gossamer Bio (NASDA - Benzinga
Matinas BioPharma Holdings Inc (MTNB) Institutional Confidence - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Matinas BioPharma Holdings Inc (MTNB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Matinas Biopharma Holdings, Inc. Revenue Breakdown – AMEX:MTNB - TradingView
Trending Stocks Today | Matinas BioPharma Surges 44.65% Post-Market - Moomoo
Matinas BioPharma Ends At-The-Market Sales Agreement - TipRanks
Matinas BiopharmaBtig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026SEC Filing - TradingView
Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties - TradingView
Matinas BioPharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell LNC Platform Technology and Lead Product Candidate M - Hydrogen Central
[425] Matinas BioPharma Holdings, Inc. Business Combination Communication - Stock Titan
Matinas BioPharma Holdings Inc (NYSE: MTNB) Share Price, MTNB Stock News, MTNB Share Price & Updates - Kalkine
Matinas BioPharma (NYSE: MTNB) to combine with GH Power in new Ontario holdco - Stock Titan
GH Power Goes Public via Matinas BioPharma Merger - Fuel Cells Works
GH Power To Go Public Through Business Combination With Matinas BioPharma - Pulse 2.0
Nasdaq Surges Over 100 Points; Bank of America Earnings Top Views - Sahm
Hezbay builds 9.54% position in Matinas BioPharma (MTNB) - Stock Titan
Matinas BioPharma forms business tie-up with GH Power to create clean energy and green hydrogen company - ROI-NJ
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
United StatesLowenstein Represents Matinas BioPharma In Strategic Business Combination With GH Power And Divestiture Of Matinas BioPharma Nanotechnologies, Inc. - Mondaq
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
4.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):